Francis Gerz
Francis Gerz is a commentator who recently criticized the pharmaceutical industry's tactics, describing them as 'cheap extortion' against Switzerland in light of ongoing discussions about drug pricing and the implications of U.S. policies under former President Trump.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 3 | 4.33 | 0.24% | +10% | 8,654,622 | 22,506 | $700,000 | 1,820$ |
| Totals | 3 | 8,654,622 | 22,506 | $700,000 | 1,820$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Francis Gerz criticizes the regulatory environment in Switzerland, particularly in the construction sector.
3
Switzerland:
Francis Gerz expresses confusion over the article's perspective on nationalism and technology.
5
Switzerland:
Francis Gerz commented on the need for Europe to develop a comprehensive strategy in the automotive industry.
5
Switzerland:
Francis Gerz expresses skepticism about Switzerland's ability to plan large construction projects.
3
Switzerland:
Francis Gerz expresses his views on the Berner police and the situation in Lausanne and Basel.
5
Switzerland:
Francis Gerz comments on the power of the pharmaceutical industry in Switzerland.
5
Switzerland:
Francis Gerz criticized the misuse of legal recourse in Switzerland's construction processes.
3
Switzerland:
Francis Gerz commented on the NZZ's criticism of the Service-Citoyen-Initiative.
4
Switzerland:
Francis Gerz commented that the situation is cheap extortion against Switzerland.
3